Th-1 Dendritic Cell Immunotherapy

Th-1 dendritic cell immunotherapy · Diakonos Oncology Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Th-1 Dendritic Cell Immunotherapy, covering 2025-05-25 to 2025-05-25. Get the full timeline:

Most recent: Clinical Trial Update: Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma [Phase 1]